“Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials”, J of Skin, vol. 3, p. S38, Nov. 2019, doi: 10.25251/skin.3.supp.38.